Table 11. Characteristics of BCPs in the African and Caucasian populations.
| Patients | ||
|---|---|---|
| African (n = 18) | Caucasian (n = 35) | |
| No. (%) | No. (%) | |
| Stage | ||
| I | 0 | 16 (45.7) |
| II | 0 | 12 (34.3) |
| III | 3 (16.7) | 1 (2.9) |
| IV | 2 (11.1) | 0 |
| Unknown/missing | 13 (72.2) | 6 (17.1) |
| PgR | ||
| Negative (<10%) | - | 10 (33.3) |
| Positive (≥10%) | - | 20 (66.7) |
| Unknown/missing | 18 | 5 |
| HER2 | ||
| Negative | - | 27 (90.0) |
| Positive | - | 3 (10.0) |
| Unknown/missing | 18 | 5 |
| Mib1 | ||
| Negative (≤20%) | - | 20 (66.7) |
| Positive (>20%) | - | 10 (33.3) |
| Unknown/missing | 18 | 5 |
| Neoadjuvant chemotherapy | ||
| No | - | 29 (96.7) |
| Yes | - | 1 (3.3) |
| Unknown/missing | 18 | 5 |
| Surgery | ||
| No | 0 | 1 (3.3) |
| Yes | 1 (5.6) | 29 (96.7) |
| Unknown/missing | 17 | 5 |
| Hormone therapy | ||
| Adjuvant | 0 | 25 (83.3) |
| Advanced | 12 (66.7) | 3 (10.0) |
| Unknown/missing | - | 5 |
| Chemotherapy | ||
| Adjuvant | 0 | 11 (36.7) |
| Advanced | 17 (94.4) | 2 (6.7) |
| Unknown/missing | - | 5 |
| Radiotherapy | ||
| Adjuvant | 0 | 23 (76.7) |
| Advanced | 2 (11.1) | 0 |
| Unknown/missing | - | 5 |